Price T Rowe Associates Inc Ovid Therapeutics Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 17,396 shares of OVID stock, worth $18,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,396
Previous 17,396
-0.0%
Holding current value
$18,265
Previous $14,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding OVID
# of Institutions
75Shares Held
39MCall Options Held
37.4KPut Options Held
500-
Rubric Capital Management LP New York, NY5.32MShares$5.58 Million0.17% of portfolio
-
Madison Avenue Partners, LP New York, NY4.12MShares$4.32 Million0.6% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$4.19 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$4.05 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$3.3 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $73.9M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...